SentryPath: a mechanistic protocol-ranking simulator with leave-one-trial-out cross-validation across 13 phase-III oncology randomised controlled trials and a pre-registered prospective forecast
SentryPath is a mechanistic simulator that cross-validates across 13 oncology trials and forecasts trial outcomes with 3.7% mean error in NSCLC.
bioRxiv · Jun 29, 2026 · PreprintBioinformatics